Efficacy Of Cavinton In The Treatment Of Patients With Chronic Blood Flow Insufficiency. Russian Multicenter Clinical-epidemiological Program "CALIPSO"

Effect Increase
Trial Design Cohort
Trial Length 1-6 months
Number of Subjects 1011
Sex Both Genders
Age Range 45-64, 65+
Notes for this study:
Intravenous infusions during first week of vinpocetine administration, sustained with an oral dose at 30mg for 90 days and in patients of cerebrovascular insufficiency associated with arterial hypertension was able to significantly improve the symptoms associate dwith cognitive decline.

Physical balance was improved as assessed by the Tinnetti rating scale, although power output was not measured (for the rating 'functionality in the elderly')